[go: up one dir, main page]

WO2009142428A3 - Composition pharmaceutique destinée au traitement de l'éjaculation précoce - Google Patents

Composition pharmaceutique destinée au traitement de l'éjaculation précoce Download PDF

Info

Publication number
WO2009142428A3
WO2009142428A3 PCT/KR2009/002636 KR2009002636W WO2009142428A3 WO 2009142428 A3 WO2009142428 A3 WO 2009142428A3 KR 2009002636 W KR2009002636 W KR 2009002636W WO 2009142428 A3 WO2009142428 A3 WO 2009142428A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
premature ejaculation
pharmaceutical composition
provides
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/002636
Other languages
English (en)
Other versions
WO2009142428A2 (fr
Inventor
Hyun Uk Seol
Young Sung Lee
Young Hun Kim
Kyeong Bae Kim
Jeong Min Seo
Kyoung Kyu Ahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuhan Corp
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41340672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2009142428(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to AU2009249972A priority Critical patent/AU2009249972A1/en
Priority to JP2011510419A priority patent/JP5410512B2/ja
Priority to BRPI0912890A priority patent/BRPI0912890A2/pt
Priority to CA2722845A priority patent/CA2722845A1/fr
Priority to US12/993,418 priority patent/US8461146B2/en
Application filed by Yuhan Corp filed Critical Yuhan Corp
Priority to CN2009801180916A priority patent/CN102036669B/zh
Priority to EP09750750A priority patent/EP2296665A4/fr
Priority to MX2010012179A priority patent/MX2010012179A/es
Publication of WO2009142428A2 publication Critical patent/WO2009142428A2/fr
Publication of WO2009142428A3 publication Critical patent/WO2009142428A3/fr
Anticipated expiration legal-status Critical
Priority to ZA2010/09072A priority patent/ZA201009072B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une composition pharmaceutique orale destinée au traitement de l'éjaculation précoce. Ladite composition permet de traiter de façon remarquablement efficace l'éjaculation précoce tout en minimisant les effets secondaires de type nausées, vomissements, somnolence, sédation, excitation et perte de poids, etc.
PCT/KR2009/002636 2008-05-19 2009-05-19 Composition pharmaceutique destinée au traitement de l'éjaculation précoce Ceased WO2009142428A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
MX2010012179A MX2010012179A (es) 2008-05-19 2009-05-19 Composicion farmaceutica para el tratamiento de eyaculacion prematura.
EP09750750A EP2296665A4 (fr) 2008-05-19 2009-05-19 Composition pharmaceutique destinée au traitement de l'éjaculation précoce
BRPI0912890A BRPI0912890A2 (pt) 2008-05-19 2009-05-19 composição farmacêutica para o tratamento de ejaculação precoce
CA2722845A CA2722845A1 (fr) 2008-05-19 2009-05-19 Composition pharmaceutique destinee au traitement de l'ejaculation precoce
US12/993,418 US8461146B2 (en) 2008-05-19 2009-05-19 Pharmaceutical composition for the treatment of premature ejaculation
AU2009249972A AU2009249972A1 (en) 2008-05-19 2009-05-19 Pharmaceutical composition for the treatment of premature ejaculation
CN2009801180916A CN102036669B (zh) 2008-05-19 2009-05-19 用于治疗早泄的药物组合物
JP2011510419A JP5410512B2 (ja) 2008-05-19 2009-05-19 早漏治療用医薬組成物
ZA2010/09072A ZA201009072B (en) 2008-05-19 2010-12-17 Pharmaceutical composition for the treatment of premature ejaculation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20080046199 2008-05-19
KR10-2008-0046199 2008-05-19

Publications (2)

Publication Number Publication Date
WO2009142428A2 WO2009142428A2 (fr) 2009-11-26
WO2009142428A3 true WO2009142428A3 (fr) 2010-02-25

Family

ID=41340672

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/002636 Ceased WO2009142428A2 (fr) 2008-05-19 2009-05-19 Composition pharmaceutique destinée au traitement de l'éjaculation précoce

Country Status (13)

Country Link
US (1) US8461146B2 (fr)
EP (1) EP2296665A4 (fr)
JP (1) JP5410512B2 (fr)
KR (1) KR101298348B1 (fr)
CN (1) CN102036669B (fr)
AU (1) AU2009249972A1 (fr)
BR (1) BRPI0912890A2 (fr)
CA (1) CA2722845A1 (fr)
CO (1) CO6280474A2 (fr)
MX (1) MX2010012179A (fr)
RU (1) RU2010151969A (fr)
WO (1) WO2009142428A2 (fr)
ZA (1) ZA201009072B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009142428A2 (fr) 2008-05-19 2009-11-26 Yuhan Corporation Composition pharmaceutique destinée au traitement de l'éjaculation précoce
BR112013033475A2 (pt) * 2011-06-28 2017-12-19 Ctc Bio Inc composição farmacêutica para tratamento, prevenção ou melhora da ejaculação precoce e método para tratamento, prevenção ou melhora da ejaculação precoce
KR101082802B1 (ko) * 2011-08-19 2011-11-11 건일제약 주식회사 8-하이드록시클로미프라민 또는 그의 염을 포함하는 조루의 예방 또는 치료용 약학 조성물
CN102755322B (zh) * 2012-07-24 2013-12-11 兆科药业（广州）有限公司 一种乐卡地平和阿托伐他汀复方制剂
EP3090732B1 (fr) * 2013-12-31 2024-07-24 CTC Bio, Inc. Composition pharmaceutique contenant de la clomipramine et son procédé de préparation
CN108619122A (zh) * 2017-03-15 2018-10-09 王大伟 治疗早泄的药物组合物
EP3646871A1 (fr) * 2018-10-30 2020-05-06 SEROJAC PME Handels GmbH Traitement et prévention de l'éjaculation précoce (pe)
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495154B1 (en) * 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
WO2008037045A2 (fr) 2006-09-28 2008-04-03 Medley S.A. Indústria Farmacêutica Composition pharmaceutique et méthode de traitement d'une dysfonction sexuelle, dispositif contenant le médicament et utilisation de ce dernier
WO2009142428A2 (fr) 2008-05-19 2009-11-26 Yuhan Corporation Composition pharmaceutique destinée au traitement de l'éjaculation précoce

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
EVANOFF, A. ET AL.: "Treatment of premature ejaculation", THE JOURNAL OF FAMILY PRACTICE, vol. 46, no. 4, 1998, pages 280 - 281, XP008136903 *
KIM, SAE CHUL ET AL.: "Efficacy and Safety of Fluoxetine, Sertraline and Clomipramine in Patient with Premature Ejaculation: a Double-Blind, Placebo-Blind, Placebo Controlled study", JOURNAL OF UROLOGY, vol. 159, no. 2, February 1998 (1998-02-01), pages 425 - 427, XP008017113 *
MCMAHON, C. G. ET AL.: "Pharmacological treatment of premature ejaculation", CURRENT OPINION IN UROLOGY, vol. 9, no. 6, 1999, pages 553 - 561, XP008136904 *
WALDINGER M. D.: "Premature ejaculation: definition and drug treatment", DRUGS, vol. 67, no. 4, 2007, pages 547 - 68, XP009130113 *

Also Published As

Publication number Publication date
US8461146B2 (en) 2013-06-11
US20110071138A1 (en) 2011-03-24
RU2010151969A (ru) 2012-06-27
CO6280474A2 (es) 2011-05-20
JP2011520952A (ja) 2011-07-21
AU2009249972A1 (en) 2009-11-26
ZA201009072B (en) 2012-03-28
WO2009142428A2 (fr) 2009-11-26
JP5410512B2 (ja) 2014-02-05
CN102036669B (zh) 2013-05-15
CN102036669A (zh) 2011-04-27
EP2296665A2 (fr) 2011-03-23
EP2296665A4 (fr) 2012-08-01
MX2010012179A (es) 2010-12-07
KR101298348B1 (ko) 2013-08-20
BRPI0912890A2 (pt) 2015-10-20
CA2722845A1 (fr) 2009-11-26
KR20090120423A (ko) 2009-11-24

Similar Documents

Publication Publication Date Title
WO2009142428A3 (fr) Composition pharmaceutique destinée au traitement de l'éjaculation précoce
IL253038A0 (en) Preparations and methods for the treatment or prevention of infections. my voice
WO2010132882A8 (fr) Compositions sublinguales de dexmédétomidine et leurs procédés d'utilisation
EP2194104A4 (fr) Composition pour la formation d'un film hydrophile et élément hydrophile
WO2007146965A3 (fr) Composés destinés au traitement d'une maladie périodontale
IN2012DN01233A (fr)
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
WO2009129246A3 (fr) Compositions et leurs procédés de préparation et d'utilisation
WO2009121039A3 (fr) Administration de compositions de benzodiazépine
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
WO2011009039A3 (fr) Produit pharmaceutique pour administration par voie orale comprenant mgbg et procédés de traitement de maladie
WO2008073332A3 (fr) Compositions de créatine pour traitement cutané
WO2008052139A3 (fr) Doxepine à dose ultrafaible, et ses procédés d'utilisation pour traiter des troubles du sommeil
WO2009115084A3 (fr) Nouveaux dérivés de pyrrolopyrimidine et leurs utilisations
WO2008046865A3 (fr) Système d'alimentation à long terme pour personnes agées
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
WO2010049449A3 (fr) Nouveaux sels de sunitinib
ZA201003794B (en) Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
WO2007136741A3 (fr) N-desméthyldoxépine et procédés pour traiter les troubles du sommeil l'utilisant
IL186707A (en) Mitotic quinine inhibitors and medical preparations containing them
WO2008137134A3 (fr) Bromhydrate d'élétriptan amorphe et son procédé de préparation, et autres formes de bromhydrate d'élétriptan
WO2011147034A8 (fr) Composés conjugués prostaglandine-bisphosphonate, leurs méthodes de fabrication et leurs utilisations
WO2011014520A3 (fr) Composés et compositions pouvant servir de modulateurs de l'activité du gpr119
WO2010042212A3 (fr) Méthodes de traitement prophylactique ou thérapeutique de la douleur à l'aide de dérivés de spicamycine
TW200800993A (en) Organic compounds

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980118091.6

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09750750

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2722845

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/A/2010/012179

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2011510419

Country of ref document: JP

Ref document number: 12993418

Country of ref document: US

Ref document number: 12010502582

Country of ref document: PH

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010111945

Country of ref document: EG

WWE Wipo information: entry into national phase

Ref document number: 8711/DELNP/2010

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2009750750

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10159129

Country of ref document: CO

Ref document number: 2009249972

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2010151969

Country of ref document: RU

ENP Entry into the national phase

Ref document number: 2009249972

Country of ref document: AU

Date of ref document: 20090519

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0912890

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20101118